Jillian Basinger
9Patents
2h-index
23Co-inventors
43Inventor score
Filing activity: May 6, 2010 → May 23, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9144557B2 | Hematopoietic growth factor mimetic small molecule compounds and their uses | Chemistry; Metallurgy | 3 | Active |
| US9102674B2 | Substituted naphthyridine and quinoline compounds as MAO inhibitors | Chemistry; Metallurgy | 2 | Active |
| US9708334B2 | Substituted 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole and 4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine compounds as GlyT1 inhibitors | Chemistry; Metallurgy | 2 | Active |
| US9150572B2 | Substituted naphthyridine and quinoline compounds as MAO inhibitors | Chemistry; Metallurgy | 2 | Active |
| US9675605B2 | Substituted naphthyridine and quinoline compounds as MAO inhibitors | Chemistry; Metallurgy | 1 | Active |
| US9622991B2 | Hematopoietic growth factor mimetic small molecule compounds and their uses | Chemistry; Metallurgy | 1 | Active |
| US8680150B2 | Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors | Physics | 0 | Active |
| US10040759B2 | Substituted azetidinyl compounds as GlyT1 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9956213B2 | Substituted naphthyridine and quinoline compounds as MAO inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.